FK506和环孢素在肝移植受者中用作初始免疫抑制时的肾毒性。 - Suppr

Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.

作者信息

Porayko M K, Textor S C, Krom R A, Hay J E, Gores G J, Wahlstrom H E, Sanchez-Urdazpal L, Richards T, Crotty P, Beaver S

机构信息

Mayo Clinic, Rochester, MN 55905.

出版信息

Transplant Proc. 1993 Feb;25(1 Pt 1):665-8.

PMID:7679835

Abstract

摘要

相似文献

Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.FK506和环孢素在肝移植受者中用作初始免疫抑制时的肾毒性。

Transplant Proc. 1993 Feb;25(1 Pt 1):665-8.

Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.

Transplant Proc. 1995 Feb;27(1):1114-6.

Cyclosporine kinetics in pediatric liver transplant recipients: impact of dose fractionation on true glomerular filtration rate.儿童肝移植受者的环孢素动力学：剂量分割对真实肾小球滤过率的影响。

Transplant Proc. 1994 Oct;26(5):2777-8.

Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipients.

Transplant Proc. 1994 Oct;26(5):2686-90.

Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.肝移植后使用FK-506和环孢素方案进行初始免疫抑制的肾毒性作用。

Mayo Clin Proc. 1994 Feb;69(2):105-11. doi: 10.1016/s0025-6196(12)61034-9.

Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.肝移植受者因肾毒性停用环孢素并不能使肾功能持续改善，反而会导致细胞性和胆管缺失性排斥反应。

Hepatology. 1994 Apr;19(4):925-32.

Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.FK506 挽救治疗急性肝移植排斥反应后出现反复排斥反应。

Transplant Proc. 1993 Apr;25(2):1988-9.

FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.FK506挽救治疗：排斥反应逆转的速度与随后巨细胞病毒疾病的发生有关。

Transplant Proc. 1993 Apr;25(2):1992-3.

Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.肾移植中长期基于环孢素和他克莫司的免疫抑制治疗对肾功能及肾小管磷酸盐处理的影响

Transplant Proc. 2006 Jan-Feb;38(1):119-22. doi: 10.1016/j.transproceed.2005.12.083.

Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.

Transplant Proc. 1995 Feb;27(1):45-9.

引用本文的文献

Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.肝移植成年受者的维持性免疫抑制：一项网状Meta分析。

Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD011639. doi: 10.1002/14651858.CD011639.pub2.

Immunosuppressive drugs in paediatric liver transplantation.儿童肝移植中的免疫抑制药物

Paediatr Drugs. 2001;3(1):43-60. doi: 10.2165/00128072-200103010-00004.

CP-123,369: a potent, orally active immunosuppressive agent.CP - 123,369：一种强效的口服活性免疫抑制剂。

Inflamm Res. 1995 Aug;44 Suppl 2:S183-4. doi: 10.1007/BF01778322.

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。

Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献